Those goals aim for 90 per cent of people living with HIV knowing their HIV status, 90 per cent of people diagnosed with HIV receiving antiretroviral therapy, and 90 per cent of people receiving antiretroviral therapy experiencing viral suppression.
“This study provides critical health information to help shape and support national and global decision-making,” said Peter Hayward, editor of The Lancet HIV.
“The estimates are also key to strengthening accountability to ensure that promises made by politicians and policymakers with regard to specific HIV targets are being delivered,” he stated.
The results of IHME’s study underscore the need for more effective efforts to prevent new infections, as well as additional funding for these efforts.
According to Financing Global Health 2015, a report published in April by IHME, annual funding globally for HIV/AIDS peaked at US$11.2 billion in 2013, but dropped to US$10.8 billion in 2015.
With slowdown in the decline of new infections and in funding for HIV/AIDS, it will be challenging to achieve the goal set by the global community to end AIDS by 2030.
The above study examines HIV mortality, prevalence, and incidence between 1980 and 2015, and is part of the Global Burden of Disease Study 2015, which provides comprehensive population health estimates on disease, injuries, and related risk factors.
About The Author
